IRVING, Texas--(BUSINESS WIRE)--Today, Lightbeam Health Solutions, the leader in population health enablement solutions and services, is pleased to announce CareSignal®, Lightbeam’s Deviceless Remote Patient Monitoring® product, has been recognized as a high-scoring vendor in the Remote Patient Monitoring (RPM) 2023 report by KLAS Research.
Lightbeam’s CareSignal product achieved an overall performance score of 93.2% in the limited data segment of the report, well above the average of 85% across all vendors. KLAS Research based the CareSignal score on feedback from 10 individual respondents across nine unique organizations. According to the report, “Interviewed customers—a mix of clinics and larger organizations—most commonly use the solution to monitor diabetes, and they tend to be highly satisfied, describing the vendor as extremely responsive and accommodating.”
“This is the first time CareSignal has been included in a report by KLAS Research, and we are humbled and energized to have achieved the highest score of any RPM company assessed,” says Blake Marggraff, CEO of Lightbeam’s CareSignal division. “Deviceless RPM enables risk-bearing organizations to scale clinical staff and reach rising-risk patients or members. By meeting patients where they are, our client-partners build upon the deep, caring relationships they have worked so hard to form, all while elevating clinical and financial performance under increasingly challenging value-based care models and financial constraints. Together, we are privileged to truly enable population health by serving the individuals who have the most to gain.”
CareSignal deviceless technology is unique in the RPM market. Instead of requiring patients to learn how to use an all-new device, CareSignal leverages text messages and phone calls to engage patients with over 30+ condition-specific programs, including CHF, COPD, diabetes, and depression. Deviceless RPM drives value-based care success because of its ability to capture real-time, self-reported patient data and employs artificial intelligence to encourage long-term patient engagement and enable timely interventions. Speaking to this success, CareSignal client-partners generated $59 million in savings for the Medicare Shared Savings Program (MSSP) in performance year (PY) 2021. Lightbeam continues to innovate the healthcare industry in all aspects, having recently released the industry’s first no-cost health equity strategy in-a-box solution, Radian™.
Schedule a demo with a Lightbeam expert to see how Deviceless RPM paves the way for proactive care management and timely clinical intervention. To learn more about CareSignal’s KLAS Research performance score, download the report: Remote Patient Monitoring 2023 – Healthcare Organizations Test Solutions in Rapidly Evolving Market.
KLAS is a research and insights firm on a global mission to improve healthcare. Working with thousands of healthcare professionals and clinicians, KLAS gathers data and insights on software and services to deliver timely reports and performance data that represent provider and payer voices and act as catalysts for improving vendor performance. The KLAS research team publishes reports covering the most pressing questions facing healthcare technology today, including emerging technology insights, that provide early insights on the future of healthcare technology solutions. KLAS also fosters measurement and collaboration between healthcare providers and payers and best practice adoption. Learn more at https://klasresearch.com/.
About Lightbeam Health Solutions
Lightbeam Health Solutions delivers a proven model for managing patient populations and associated risk. Lightbeam’s vision is to bring health data into the light through the use of analytics, and to provide the insight and capabilities healthcare clients need to ensure patients receive the right care at the right time. Lightbeam facilitates population health management for ACOs, payers, provider groups, health systems, and other healthcare organizations aspiring to provide superior care at a lower cost. For more information, visit www.lightbeamhealth.com, and follow Lightbeam on LinkedIn and Twitter.